Gara Jalqabaatti › Kansarii Prostate › Nebraska

Qorannoo klinikaalii Kansarii Prostate Nebraska keessatti

Qorannoo 27 Kansarii Prostate f Nebraska keessatti hirmaatuu jiru.

Magaalota Nebraska keessatti

Takkalaa qorannoo (Ingiliffa)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

CHI Health Saint Francis, Grand Island
CHI Health Good Samaritan, Kearney
Alegent Health Immanuel Medical Center, Omaha
fi 2 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Nebraska Medicine-Bellevue, Bellevue
Nebraska Medicine-Village Pointe, Omaha
University of Nebraska Medical Center, Omaha

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Urology Cancer Center, PC, Omaha

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06136650

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Nebraska Cancer Specialists, Omaha

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06780670

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Nebraska Cancer Specialists, Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06855277

PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer

University of Nebraska Medical Center, Omaha

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 30 fi ol · Dhiroota · Haaromfame 21-Ful-2026 · NCT07234981

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

XCancer, Omaha

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Dhiroota · Haaromfame 15-Ful-2026 · NCT07581184

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

XCancer Omaha LLC, Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Nebraska Medicine-Bellevue, Bellevue
Nebraska Medicine-Village Pointe, Omaha
University of Nebraska Medical Center, Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05946213

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Research Site, Omaha

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 hanga 99 · Dhiroota · Haaromfame 27-Hag-2026 · NCT07590934

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Research Site, Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 26-Hag-2026 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

XCancer Omaha, Omaha

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Dhiroota · Haaromfame 24-Hag-2026 · NCT07745361

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Nebraska Cancer Specialists, Omaha

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Dhiroota · Haaromfame 20-Hag-2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

CHI Health Good Samaritan, Kearney
Alegent Health Bergan Mercy Medical Center, Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 19-Hag-2026 · NCT04423211

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

University of Nebraska Medical Center, Omaha

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 30 fi ol · Dhiroota · Haaromfame 19-Hag-2026 · NCT07237269

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

CHI Health Saint Francis, Grand Island
CHI Health Good Samaritan, Kearney
Alegent Health Immanuel Medical Center, Omaha
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Ado-2026 · NCT06592924

Integrated Cancer Repository for Cancer Research

Mary Lanning Healthcare, Morrison Cancer Center, Hastings
Faith Regional Health Services, Carson Cancer Center, Norfolk
Great Plains Regional Medical Center, North Platte
fi 3 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
XCancer Omaha / Urology Cancer Center, Omaha

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05283330

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Urology Cancer Center PC, Omaha
Nebraska Cancer Specialists, Omaha

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 hanga 100 · Dhiroota · Haaromfame 04-Wax-2026 · NCT05803941

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

XCancer Omaha / Urology Cancer Center, Omaha

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Cam-2026 · NCT05413850

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Research Site, Omaha

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Dhiroota · Haaromfame 12-Cam-2026 · NCT06879041

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

CHI Health Good Samaritan, Kearney
Saint Elizabeth Regional Medical Center, Lincoln
Alegent Health Immanuel Medical Center, Omaha
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Dhiroota · Haaromfame 29-Ama-2026 · NCT05806515

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Nebraska Medicine-Bellevue, Bellevue
Nebraska Medicine-Village Pointe, Omaha
University of Nebraska Medical Center, Omaha

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ama-2026 · NCT06470243

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

University of Nebraska Medical Center, Omaha

Namoota walitti qabaa jira

Umuriin 19 fi ol · Dhiroota · Haaromfame 05-Sad-2025 · NCT05754580

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Omaha

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Nebraska Medicine-Bellevue, Bellevue
Nebraska Methodist Hospital, Omaha
Nebraska Medicine-Village Pointe, Omaha
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2025 · NCT03678025

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.